These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 21417995)

  • 1. Telomerase: structure, functions, and activity regulation.
    Zvereva MI; Shcherbakova DM; Dontsova OA
    Biochemistry (Mosc); 2010 Dec; 75(13):1563-83. PubMed ID: 21417995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere structure and telomerase in health and disease (review).
    Gomez DE; Armando RG; Farina HG; Menna PL; Cerrudo CS; Ghiringhelli PD; Alonso DF
    Int J Oncol; 2012 Nov; 41(5):1561-9. PubMed ID: 22941386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Telomerase and telomere: their structure and dynamics in health and disease].
    Mengual Gómez DL; Armando RG; Farina HG; Gómez DE
    Medicina (B Aires); 2014; 74(1):69-76. PubMed ID: 24561847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere length maintenance in aging and carcinogenesis.
    Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F
    Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
    Babizhayev MA; Yegorov YE
    J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).
    Engelhardt M; Martens UM
    Oncol Rep; 1998; 5(5):1043-52. PubMed ID: 9683806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Telomeres, telomerase and cancer].
    Soria JC; Rixe O
    Bull Cancer; 1997 Oct; 84(10):963-70. PubMed ID: 9435798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in telomerase activity and telomere length during human T lymphocyte senescence.
    Pan C; Xue BH; Ellis TM; Peace DJ; Díaz MO
    Exp Cell Res; 1997 Mar; 231(2):346-53. PubMed ID: 9087176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
    Raymond E; Faivre S; Dieras V; Von Hoff D
    Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomeres, telomerase, and tumorigenesis--a review.
    Wai LK
    MedGenMed; 2004 Jul; 6(3):19. PubMed ID: 15520642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple pathways to cellular senescence: role of telomerase repressors.
    Oshimura M; Barrett JC
    Eur J Cancer; 1997 Apr; 33(5):710-5. PubMed ID: 9282109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-Quadruplex ligands: Potent inhibitors of telomerase activity and cell proliferation in Plasmodium falciparum.
    Calvo EP; Wasserman M
    Mol Biochem Parasitol; 2016 May; 207(1):33-8. PubMed ID: 27217226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in telomerase and the inhibitors].
    Zhou Y; Gong XG
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):604-7. PubMed ID: 11910748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase expression in lung preneoplasia and neoplasia.
    Lantuéjoul S; Salon C; Soria JC; Brambilla E
    Int J Cancer; 2007 May; 120(9):1835-41. PubMed ID: 17311257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomeres and telomerase: implications for cancer and aging.
    Shay JW; Wright WE
    Radiat Res; 2001 Jan; 155(1 Pt 2):188-193. PubMed ID: 11121233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomeres and telomerase: Pharmacological targets for new anticancer strategies?
    Pendino F; Tarkanyi I; Dudognon C; Hillion J; Lanotte M; Aradi J; Ségal-Bendirdjian E
    Curr Cancer Drug Targets; 2006 Mar; 6(2):147-80. PubMed ID: 16529544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An introduction to telomeres and telomerase.
    Bibby MC
    Mol Biotechnol; 2003 Jul; 24(3):295-301. PubMed ID: 12777695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase inhibitors in cancer therapy: current status and future directions.
    Incles CM; Schultes CM; Neidle S
    Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.